[1]
Corona-Ortega, M.T. et al. 2018. Preclinical studies for a cationic liposome formulation containing Il-2 Intended for the treatment of Human Tumors. Archives of Pharmacy and Pharmaceutical Sciences. 2, 1 (Oct. 2018), 051–059. DOI:https://doi.org/10.29328/journal.apps.1001010.